drugset / Trial / NCT01025635

Safety and Efficacy of Azelaic Acid Foam, 15% in Papulopustular Rosacea

NCT01025635

Phase 2 Completed 401 enrolled LEO Pharma Bayer · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will investigate the safety and efficacy of a new formulation of an existing medication for the treatment of papulopustular rosacea. The study will test the active ingredient plus foam against foam alone.

Timeline

Start
2009-12
Primary completion
2010-08
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Azelaic acid Small molecule 15 % Topical

Indications